We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Boundless Bio Inc | NASDAQ:BOLD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.07 | 1.75% | 4.07 | 4.07 | 4.16 | 4.10 | 3.90 | 4.00 | 42,293 | 18:55:40 |
Delaware
|
001-37833
|
46-1606174
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
|
|
|
600 California Street, 17th Floor
|
San Francisco
|
California
|
94108
|
(Address of Principal Executive Offices)
|
|
|
(Zip Code)
|
Title of each class
|
Trading Symbol
|
Name of exchange on which registered
|
Common Stock, par value $0.00001 per share
|
BOLD
|
The Nasdaq Global Market
|
|
Audentes Therapeutics, Inc.
|
|
Date: October 8, 2019
|
By:
|
/s/ Mark Meltz
|
|
|
Mark Meltz
|
|
|
Senior Vice President, General Counsel
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Year Boundless Bio Chart |
1 Month Boundless Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions